Availability and Supply of Novel Psychoactive Substances

Novel Psychoactive Substances: Classification, Pharmacology and Toxicology

Volumn , Issue , 2013, Pages 55-77

  Smith, Silas W ^a,b   Garlich, Fiona M ^c,d  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK CITY POISON CONTROL CENTER   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d Poison and Drug Information Service Calgary   (Canada)

Author keywords

Availability; Internet; Legal; Market; Novel psychoactive compound; Online; Price; Supply; Vendor

Indexed keywords

EID: 84903801437     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-415816-0.00003-1     Document Type: Chapter

References (175)

1. EMCDDA. Online sales of new psychoactive substances/legal highs: Summary of results from the 2011 multilingual snapshots. European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal; 2011.
2. Hillebrand J, Olszewski D, Sedefov R Legal highs on the internet. Subst Use Misuse 2010, 45:330-340.
3. U.S. Drug Enforcement Administration, Department of justice.2006 General information regarding the combat methamphetamine epidemic act of 2005 [Title VII of Public Law 109-177].
4. United Nations. United Nations convention against illicit traffic in NARCOTIC DRUGS AND PSYCHOACTIVE Substances, 1988. United Nations, Austria, Vienna; 2003.
5. US Drug Enforcement Administration, Department of Justice Control of a chemical precursor used in the illicit manufacture of fentanyl as a list I chemical. Final rule. Fed Regist 2008, 73:43355-43357.
6. Centers for Disease Control and Prevention (CDC). Youth risk behavior surveillance - United States, 2011. MMWR Morb Mortal Wkly Rep 2012, 61(SS-4):1-162.
7. SAMHSA Center for behavioral health statistics and quality. The DAWN report: highlights of the 2010 drug abuse warning network (DAWN) findings on drug-related emergency department visits 2012, Substance Abuse and Mental Health Services Administration, Rockville, MD.
8. SAMHSA Results from the 2010 national survey on drug use and health: summary of national findings. NSDUH series H-41, HHS publication no. (SMA) 11-4658 2011, Substance Abuse and Mental Health Services Administration, Rockville, Maryland.
9. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE Monitoring the future national results on adolescent drug use: Overview of key findings, 2011 2012, Institute for Social Research, The University of Michigan, Ann Arbor, Michigan.
10. U.S. Drug Enforcement Administration. Stats & facts. Available: <>; 2011 [accessed 06.07.12]. http://www.justice.gov/dea/statistics.html#seizures.
11. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Seizures data (SZR) Table SZR-21. Other substances seized, 2004 to 2009. Available: <>; 2011 [accessed 06.07.12]. http://www.emcdda.europa.eu/stats11/szrtab21.
12. Bronstein AC, Spyker DA, Cantilena LR, Green JL, Rumack BH, Dart RC Annual report of the American association of poison control centers' national poison data system (NPDS): 28th annual report. Clin Toxicol (Phila) 2010, 49:910-941. 2011.
13. US Drug Enforcement Administration, Office of Diversion Control. National forensic laboratory information system special report: Synthetic cannabinoids and synthetic cathinones reported in NFLIS, 2009-2010. US Drug Enforcement Administration, Springfield, Virginia; 2011.
14. National Institute on Drug Abuse (NIDA). Drugs of abuse information. Available: <>; 2011 [accessed 06.07.12]. http://www.drugabuse.gov/drugs-abuse.
15. Substance Abuse and Mental Health Services Administration. Substances. Available: <>; 2011 [accessed 06.07.12]. http://store.samhsa.gov/facet/Substances.
16. Legleye S, Ben Lakhdar C, Spilka S Two ways of estimating the euro value of the illicit market for cannabis in France. Drug Alcohol Rev 2008, 27:466-472.
17. United Nations Office on Drugs and Crime (UNODC). World drug report 2012. Sales No. E.12.XI.1. United Nations, New York, NY; 2012.
18. Kerwin J Doors of deception - The diaspora of designer drugs. Drug Test Anal 2011, 3:527-531.
19. Vardakou I, Pistos C, Spiliopoulou C Spice drugs as a new trend: mode of action, identification and legislation. Toxicol Lett 2010, 197:157-162.
20. Hu X, Primack BA, Barnett TE, Cook RL College students and use of K2: an emerging drug of abuse in young persons. Subst Abuse Treat Prev Policy 2011, 6:16.
21. Vandrey R, Dunn KE, Fry JA, Girling ER A survey study to characterize use of Spice products (synthetic cannabinoids). Drug Alcohol Depend 2012, 120:238-241.
22. Lange JE, Reed MB, Croff JM, Clapp JD College student use of Salvia divinorum. Drug Alcohol Depend 2008, 94:263-266.
23. Wu LT, Woody GE, Yang C, Li JH, Blazer DG Recent national trends in Salvia divinorum use and substance-use disorders among recent and former Salvia divinorum users compared with nonusers. Subst Abuse Rehabil 2011, 2011:53-68.
24. Perron BE, Ahmedani BK, Vaughn MG, Glass JE, Abdon A, Wu LT Use of Salvia divinorum in a nationally representative sample. Am J Drug Alcohol Abuse 2011, 38:108-113.
25. Dargan PI, Albert S, Wood DM Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change. QJM 2010, 103:875-879.
26. Winstock A The 2011 Mixmag drugs survey. Mixmag 2011, 238:49-59. Available: [accessed 06.07.12].
27. Schep LJ, Slaughter RJ, Vale JA, Beasley DM, Gee P The clinical toxicology of the designer party pills benzylpiperazine and trifluoromethylphenylpiperazine. Clin Toxicol (Phila) 2011, 49:131-141.
28. Wilkins C, Sweetsur P, Girling M Patterns of benzylpiperazine/trifluoromethylphenylpiperazine party pill use and adverse effects in a population sample in New Zealand. Drug Alcohol Rev 2008, 27:633-639.
29. Cohen BM, Butler R BZP-party pills: a review of research on benzylpiperazine as a recreational drug. Int J Drug Policy 2011, 22:95-101.
30. Schmidt MM, Sharma A, Schifano F, Feinmann C Legal highs on the net-Evaluation of UK-based Websites, products and product information. Forensic Sci Int 2011, 206:92-97.
31. McCandless D Exotic, legal highs become big business as 'headshops' boom. The Guardian 2006, Available: [accessed 06.07.12].
32. North American Herbal Incense Trade Association. NAHITA statement of positions. Available: <>; 2011 [accessed 06.07.12]. http://keepitlegal.org/node/93.
33. Paynter, B.2011 The big business of synthetic highs. Bloomberg Businessweek. Available: <> [accessed 06.07.12]. http://www.businessweek.com/magazine/content/11_26/b4234058348635.htm.
34. Evaluation and Inspections Division. Office of the Inspector General. Follow-up review of the drug enforcement administration's efforts to control the diversion of controlled pharmaceuticals. Evaluations and inspections report I-2006-004. US Department of Justice, Available: <>; 2006 [accessed 06.07.12]. http://www.justice.gov/oig/reports/DEA/e0604/final.pdf.
35. US Drug Enforcement Administration Office of diversion control. National forensic laboratory information system: year 2009 annual report 2010, US Drug Enforcement Administration, Springfield, Virginia.
36. US Drug Enforcement Administration Office of diversion control. National forensic laboratory information system: year 2010 annual report 2011, US Drug Enforcement Administration, Springfield, Virginia.
37. EMCDDA Report on the risk assessment of mephedrone in the framework of the council decision on new psychoactive substances 2011, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal.
38. Office of Diversion Control, Drug and Chemical Evaluation Section. 2011 4-methylmethcathinone (mephedrone). US Department of Justice, Drug Enforcement Administration, Washington, D.C.
39. Office of Diversion Control, Drug and Chemical Evaluation Section. 2011 3,4-methylenedioxypyrovalerone (MDPV). US Department of Justice, Drug Enforcement Administration, Washington, DC.
40. Wiley JL, Compton DR, Dai D, et al. Structure-activity relationships of indole- and pyrrole-derived cannabinoids. J Pharmacol Exp Ther 1998, 285:995-1004.
41. Huffman JW, Dong D, Martin BR, Compton DR Design, synthesis and pharmacology of cannabimimetic indoles. Bioorg Med Chem Lett 1994, 4:563-566.
42. Atwood BK, Huffman J, Straiker A, Mackie K JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB receptor agonist. Br J Pharmacol 2010, 160:585-593.
43. Monte AP, Marona-Lewicka D, Parker MA, Wainscott DB, Nelson DL, Nichols DE Dihydrobenzofuran analogues of hallucinogens. 3. Models of 4-substituted (2,5-dimethoxyphenyl)alkylamine derivatives with rigidified methoxy groups. J Med Chem 1996, 39:2953-2961.
44. Parker MA, Marona-Lewicka D, Lucaites VL, Nelson DL, Nichols DE A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptor. J Med Chem 1998, 41:5148-5149.
45. Sainsbury PD, Kicman AT, Archer RP, King LA, Braithwaite RA Aminoindanes - the next wave of 'legal highs'?. Drug Test Anal 2011, 3:479-482.
46. Whalen J In quest of legal high, chemists outfox law. Wall St J 2010, Available: [accessed 06.07.12].
47. Nichols D Legal highs: the dark side of medicinal chemistry. Nature 2011, 469:7.
48. Elliott SP Fatal poisoning with a new phenylethylamine: 4-methylthioamphetamine (4-MTA). J Anal Toxicol 2000, 24:85-89.
49. Andreasen MF, Telving R, Birkler RI, Schumacher B, Johannsen M A fatal poisoning involving Bromo-Dragonfly. Forensic Sci Int 2009, 183:91-96.
50. Wood DM, Looker JJ, Shaikh L, et al. Delayed onset of seizures and toxicity associated with recreational use of Bromo-Dragonfly. J Med Toxicol 2009, 5:226-229.
51. Hill SL, Thomas SH Clinical toxicology of newer recreational drugs. Clin Toxicol (Phila) 2011, 49:705-719.
52. Campbell H, Cline W, Evans M, Lloyd J, Peck AW Comparison of the effects of dexamphetamine and 1-benzylpiperazine in former addicts. Eur J Clin Pharmacol 1973, 6:170-176.
53. Kahn RS, Wetzler S m-Chlorophenylpiperazine as a probe of serotonin function. Biol Psychiatry 1991, 30:1139-1166.
54. Bossong MG, Van Dijk JP, Niesink RJ Methylone and mCPP, two new drugs of abuse?. Addict Biol 2005, 10:321-323.
55. Bossong MG, Brunt TM, Van Dijk JP, et al. mCPP: an undesired addition to the ecstasy market. J Psychopharmacol 2010, 24:1395-1401.
56. Collins M Some new psychoactive substances: precursor chemicals and synthesis-driven end-products. Drug Test Anal 2011, 3:404-416.
57. Saem de Burnaga Sanchez J Sur un homologue de l'éphédrine [French]. Bulletin De La Societé Chimique De France 1929, 45:284-286.
58. US Drug Enforcement Administration, Department of Justice Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final order. Fed Regist 2011, 76:65371-65375.
59. Office of Diversion Control, Drug and Chemical Evaluation Section Background, data and analysis of synthetic cathinones: mephedrone (4-MMC), methylone (MDMC) and 3,4-methylenedioxypyrovalerone (MDPV) 2011, U.S. Department of Justice, Drug Enforcement Administration, Washington, D.C.
60. Brunt TM, Niesink RJ The drug information and monitoring system (DIMS) in the Netherlands: implementation, results and international comparison. Drug Test Anal 2011, 3:621-634.
61. Begg WG, Reid AA Meratran; a new stimulant drug. Br Med J 1956, 1:946-949.
62. Kelleher C, Christie R, Lalor K, Fox J, Bowden M, O'Donnell C An overview of new psychoactive substances and the outlets supplying them 2011, National Advisory Committee on Drugs (NACD), Dublin, Ireland.
63. Dunne, P. Misuse of Drugs Act 1975. Temporary Class Drug Notice. New Zealand Gazette 29, 833. Government of New Zealand, Wellington, New Zealand; 2012.
64. Shulgin A, Shulgin A PiHKAL: a chemical love story 1991, Transform Press, Berkeley, California.
65. Shulgin A, Shulgin A TiHKAL: the continuation 1997, Transform Press, Berkeley, California.
66. Shulgin AT, Manning T, Daley PF The Shulgin Index. Volume 1: Psychedelic phenethylamines and related compounds 2011, Transform Press, Berkeley, California.
67. Morris, H. Interview with a ketamine chemist. Vice. Available: <>; 2011 [accessed 06.07.12]. http://www.vice.com/read/interview-with-ketamine-chemist-704-v18n2.
68. Archer RP Fluoromethcathinone, a new substance of abuse. Forensic Sci Int 2009, 185:10-20.
69. EMCDDA-Europol. 2008 Annual report on the implementation of Council Decision 2005/387/JHA. European Monitoring Centre for Drugs and Drug Addiction-Europol, Lisbon, Portugal, 2009. Available: <> [accessed 06.07.12]. http://www.emcdda.europa.eu/attachements.cfm/att_77263_EN_EMCDDA-Europol_Annual_Report_Art10_2008.pdf.
70. EMCDDA-Europol. 2012 2011 Annual report on the implementation of council decision 2005/387/JHA. European Monitoring Centre for Drugs and Drug Addiction-Europol, Lisbon, Portugal. Available: <> [accessed 06.07.12]. http://www.emcdda.europa.eu/attachements.cfm/att_155113_EN_EMCDDA-Europol%20Annual%20Report%202011_2012_final.pdf.
71. Kikura-Hanajiri R, Uchiyama N, Goda Y Survey of current trends in the abuse of psychotropic substances and plants in Japan. Leg Med (Tokyo) 2011, 13:109-115.
72. US Drug Enforcement Administration, Office of Diversion Control, Drug and Chemical Evaluation Section. 2011 2,5-dimethoxy-4-(n)-propylthiophenethylamine. U. Department of Justice. Available: <> [accessed 29.12.11]. http://www.deadiversion.usdoj.gov/drugs_concern/2ct7.pdf.
73. ACMD Consideration of the novel psychoactive substances ('legal highs') 2011, Advisory Council on the Misuse of Drugs, London, UK.
74. Vardakou I, Pistos C, Spiliopoulou C Drugs for youth via Internet and the example of mephedrone. Toxicol Lett 2011, 201:191-195.
75. International Narcotics Control Board (INCB). Report of the international narcotics control board for 2010. E/INCB/2010/1. United Nations, New York, NY; 2011.
76. Babu KM, McCurdy CR, Boyer EW Opioid receptors and legal highs: Salvia divinorum and Kratom. Clin Toxicol (Phila) 2008, 46:146-152.
77. Boyer EW, Shannon M, Hibberd PL The internet and psychoactive substance use among innovative drug users. Pediatrics 2005, 115:302-305.
78. Montagne M Drugs on the internet. I: Introduction and web sites on psychedelic drugs. Subst use Misuse 2008, 43:17-25.
79. Wax PM Just a click away: recreational drug Web sites on the Internet. Pediatrics 2002, 109(e96).
80. Deluca P, Schifano F, Psychonaut 2002 Research Group Searching the Internet for drug-related web sites: analysis of online available information on ecstasy (MDMA). Am J Addict 2007, 16:479-483.
81. Boyer EW, Lapen PT, Macalino G, Hibberd PL Dissemination of psychoactive substance information by innovative drug users. Cyberpsychol Behav 2007, 10:1-6.
82. Halpern JH, Pope HG Hallucinogens on the Internet: a vast new source of underground drug information. Am J Psychiatry 2001, 158:481-483.
83. European Commission. Young people and drugs among 15-24 year-olds. Flash EB Series #233. European Commission, Dublin, Ireland; 2008.
84. National Center for Addiction and Substance Abuse. National Survey of American Attitudes on Substance Abuse XVI: Teens and Parents. New York: Columbia University; 2011.
85. Erowid. Documenting the complex relationship between humans and psychoactives. Available: <>; 2012 [accessed 06.07.12]. http://www.erowid.org.
86. Dancesafe. Available: <>; 2012 [accessed 06.07.12]. http://dancesafe.org/.
87. Multidisciplinary Association for Psychedelic Studies (MAPS). Available: <>; 2012 [accessed 06.07.12]. http://maps.org/.
88. Bluelight. Available: <>; 2012 [accessed 06.07.12]. http://www.bluelight.ru/vb/.
89. Lycaeum. Available: <>; 2011 [accessed 24.12.11]. http://www.lycaeum.org/.
90. The Shroomery. Available: <>; 2012 [accessed 06.07.12]. http://www.shroomery.org.
91. ACMD Consideration of the cathinones 2010, Advisory Council on the Misuse of Drugs, London, UK.
92. International Narcotics Control Board (INCB). Report of the international narcotics control board for 2001. E/INCB/2001/1. United Nations, New York, NY; 2001.
93. International Narcotics Control Board (INCB). Report of the international narcotics control board for 1997. E/INCB/1997/1. United Nations, New York, NY; 1997.
94. Klein CA Psychotropics without borders: ethics and legal implications of internet-based access to psychiatric medications. J Am Acad Psychiatry Law 2011, 39:104-111.
95. Schepis TS, Marlowe DB, Forman RF The availability and portrayal of stimulants over the Internet. J Adolesc Health 2008, 42:458-465.
96. Forman RF, Marlowe DB, McLellan AT The Internet as a source of drugs of abuse. Curr Psychiatry Rep 2006, 8:377-382.
97. US Drug Enforcement Administration. FY 2012 performance budget congressional submission. US Department of Justice, Washington, DC; 2011.
98. Dev CS, Schultz DE In the mix: a customer-focused approach can bring the current marketing mix into the 21st century. Mark Manage 2005, 14:16-22.
99. Davies S, Wood DM, Smith G, et al. Purchasing 'legal highs' on the internet - is there consistency in what you get?. QJM 2010, 103:489-493.
100. Dick D, Torrance C MixMag drugs survey. Mixmag 2010, 44-53.
101. Winstock A Global drug survey. MixMag 2012, 251:68-73. Available: [accessed 05.07.12].
102. EMCDDA 2011 annual report on the state of the drugs problem in Europe 2011, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal.
103. Hoover V, Marlowe DB, Patapis NS, Festinger DS, Forman RF Internet access to Salvia divinorum: implications for policy, prevention, and treatment. J Subst Abuse Treat 2008, 35:22-27.
104. Topping A Guardian/Mixmag drug survey reveals a generation happy to chance it. The Guardian. 2012, Available: [accessed 06.07.12].
105. Maruyama T, Kawamura M, Kikura-Hanajiri R, Takayama H, Goda Y The botanical origin of kratom (Mitragyna speciosa; Rubiaceae) available as abused drugs in the Japanese markets. J Nat Med 2009, 63:340-344.
106. Corazza O, Schifano F, Farre M, et al. Designer drugs on the internet: a phenomenon out-of-control? The emergence of hallucinogenic drug Bromo-Dragonfly. Curr Clin Pharmacol 2011, 6:125-129.
107. Plant Feed Shop. Available: <>; 2011 [accessed 30.12.11]. http://www.plantfeedshop.com/.
108. Blackwell S Selling drugs on Facebook and Twitter. Death and Taxes 2010, Available: [accessed 06.07.12].
109. Wilber DQ Following antisocial elements on social media. The Washington Post. 2011, Available: ; [accessed 06.07.12].
110. Power M How I caused an international drug panic. Mixmag 2011, Available: [accessed 06.07.12].
111. US Department of Justice. National Drug Intelligence Center. Situation report. synthetic cathinones (bath salts): an emerging domestic threat. Product number 2011-S0787-004. National Drug Intelligence Center, Johnstown, Pennsylvania; 2011.
112. Capone, J..2011 A poppy panic on eBay, Courtesy of the DEA. The Fix. Available: <> [accessed 06.07.12]. http://www.thefix.com/content/poppy-panic?page=all.
113. reddit. Tell me about buying drugs from eBay [forum discussion]. Available: <>; 2011 [accessed 06.07.12]. http://www.reddit.com/r/Drugs/comments/fw1d6/tell_me_about_buying_drugs_from_ebay/.
114. eBay. Available: <>; 2011 [accessed 30/12/11]. http://www.ebay.com/.
115. Chen A The underground website where you can buy any drug imaginable. Gawker com. 2011, Available: [accessed 06.07.12].
116. Amsterdam Coffeeshop Directory.Smartshop, growshop, headshop. Available: <>; 2011 [accessed 06.07.12]. http://www.coffeeshop.freeuk.com/GenSS.html.
117. Auwarter V, Dresen S, Weinmann W, Muller M, Putz M, Ferreiros N 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?. J Mass Spectrom 2009, 44:832-837.
118. de Boer D, Bosman I A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugs. Pharm World Sci 2004, 26:110-113.
119. Schifano, F., Deluca, P., Agosti, L., Psychonaut 2002 Research Group, et al. and 2005 New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic'). J Psychopharmacol 19, 675-679.
120. Gee P, Fountain J Party on? BZP party pills in New Zealand. N Z Med J 2007, 120:U2422.
121. de Boer D, Bosman IJ, Hidvegi E, et al. Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market. Forensic Sci Int 2001, 121:47-56.
122. Spiller HA, Ryan ML, Weston RG, Jansen J Clinical experience with and analytical confirmation of bath salts and legal highs (synthetic cathinones) in the United States. Clin. Toxicol. (Phila) 2011, 49:499-505.
123. Headshops.com. Available: <>; 2011 [accessed 24.12.11]. http://www.headshops.com/.
124. HeadShopFinder.com. Available: <>; 2011 [accessed 24.12.11]. http://www.headshopfinder.com/.
125. Hughes B, Malczewski A Poland passes new law to control head shops and legal highs. Drugnet Europe 2011, 73:5. January-March.
126. Health Research Board (HRB). New report reveals the latest drug trends across Europe. Available: <>; 2011 [accessed 06.07.12]. http://www.hrb.ie/about/media/media-archive/press-release/release/149/.
127. McNamara S, Stokes S, Coleman N Head shop compound abuse amongst attendees of the drug treatment centre board. Ir Med J 2010, 103(134):136-137.
128. Long J Conference on psychoactive drugs sold in head shops and online. Drugnet Ireland Spring 2010, 33:1-3.
129. Nicholson PJ, Quinn MJ, Dodd JD Headshop heartache: acute mephedrone 'meow' myocarditis. Heart 2010, 96:2051-2052.
130. Lidder S, Dargan P, Sexton M, et al. Cardiovascular toxicity associated with recreational use of diphenylprolinol (diphenyl-2-pyrrolidinemethanol [D2PM]). J Med Toxicol 2008, 4:167-169.
131. Frohlich S, Lambe E, O'Dea J Acute liver failure following recreational use of psychotropic head shop compounds. Ir J Med Sci 2011, 180:263-264.
132. Smith C, Cardile AP, Miller M Bath salts as a legal high. Am J Med 2011, 124:e7-e8.
133. Ramsey J, Dargan PI, Smyllie M, et al. Buying 'legal' recreational drugs does not mean that you are not breaking the law. QJM 2010, 103:777-783.
134. Zuba D, Byrska B, Maciow M Comparison of herbal highs composition. Anal Bioanal Chem 2011, 400:119-126.
135. Doughty C, Walker A, Brenchley J Herbal mind altering substances: an unknown quantity?. Emerg Med J 2004, 21:253-255.
136. Meatherall R, Sharma P Foxy, a designer tryptamine hallucinogen. J Anal Toxicol 2003, 27:313-317.
137. Wood DM, Dargan PI, Button J, et al. Collapse, reported seizure - and an unexpected pill. Lancet 2007, 369:1490.
138. Winstock A, Mitcheson L, Marsden J Mephedrone: still available and twice the price. Lancet 2010, 376:1537.
139. Baker RA. 22 indicted by Feds in Syracuse-based conspiracy to traffic drug Molly. The Post-Standard. Available: <>; 2011 [accessed 06.07.12]. http://www.syracuse.com/news/index.ssf/2011/08/post_466.html.
140. European Monitoring Centre for Drugs and Drug Addiction. Drug profiles. Available: <>; 2011 [accessed 29.12.11]. http://www.emcdda.europa.eu/drug-profiles.
141. Phillips J. Britain steps up its war on legal highs. Time. Available: <>; 2011 [accessed 06.07.12]. http://www.time.com/time/world/article/0,8599,2100285,00.html.
142. Dargan PI, Sedefov R, Gallegos A, Wood DM The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone). Drug Test Anal 2011, 3:454-463.
143. Daly M, Simonson P Street drug trends survey 2011: the ketamine zone. Druglink 2011, November/December:6-9.
144. Carhart-Harris RL, King LA, Nutt DJ A web-based survey on mephedrone. Drug Alcohol Depend 2011, 118:19-22.
145. EMCDDA Thematic paper: Pilot study on wholesale drug prices in Europe 2011, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal.
146. Brandt SD, Freeman S, Sumnall HR, Measham F, Cole J Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones. Drug Test Anal 2011, 3:569-575.
147. Centers for Disease Control and Prevention (CDC) Emergency department visits after use of a drug sold as bath salts - Michigan, November 13, 2010-March 31, 2011. MMWR Morb Mortal Wkly Rep 2011, 60:624-627.
148. Schifano F, Albanese A, Fergus S, et al. Mephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues. Psychopharmacology (Berl) 2011, 214:593-602.
149. ACMD Consideration of the naphthylpyrovalerone analogues and related compounds 2010, Advisory Council on the Misuse of Drugs, London, UK.
150. Drugscope. Drug information. DrugSearch home. Available: <>; 2011 [accessed 29.12.11]. http://www.drugscope.org.uk/resources/drugsearch.
151. US Drug Enforcement Administration, Office of Diversion Control, Drug & Chemical Evaluation Section. 2011 4-bromo-2,5-dimethoxyphenethylamine. U.S. Department of Justice, Available: <> [accessed 06.07.12]. http://www.deadiversion.usdoj.gov/drugs_concern/bromo_dmp/bromo_dmp.pdf.
152. Kelly BC Legally tripping: a qualitative profile of Salvia divinorum use among young adults. J Psychoactive Drugs 2011, 43:46-54.
153. Wood DM, Davies S, Calapis A, Ramsey J, Dargan PI Novel drugs -novel branding. QJM 2012, 105:1125-1126.
154. Ivanitskaya L, Brookins-Fisher J, O Boyle I, Vibbert D, Erofeev D, Fulton L Dirt cheap and without prescription: how susceptible are young US consumers to purchasing drugs from rogue internet pharmacies?. J Med Internet Res 2010, 12:e11.
155. VIP-Legals.com. Available: <>; 2011 [accessed 31.12.11]. http://vip-legals.com/.
156. United Nations Office on Drugs and Crime (UNODC). Synthetic cannabinoids in herbal products. UN document ID number: SCITEC/24. United Nations, New York, NY; 2011.
157. National Drug Intelligence Center. Connecticut drug threat assessment. Document ID: 2002-S0377CT-001. National Drug Intelligence Center, Johnstown, Pennsylvania; 2002.
158. Sifaneck SJ, Ream GL, Johnson BD, Dunlap E Retail marijuana purchases in designer and commercial markets in New York City: sales units, weights, and prices per gram. Drug Alcohol Depend 2007, 90(Suppl. 1):S40-S51.
159. Office of National Drug Control Policy. Pulse check: trends in drug abuse January 2004. Executive Office of the President, Washington, DC; 2004.
160. Daveluy A, Miremont-Salame G, Rahis AC, et al. Medicine or ecstasy? The importance of the logo. Fundam Clin Pharmacol 2010, 24:233-237.
161. Schensul JJ, Diamond S, Disch W, Bermudez R, Eiserman J The diffusion of ecstasy through urban youth networks. J Ethn Subst Abuse 2005, 4:39-71.
162. McElrath K, O'Neill C Experiences with mephedrone pre- and post-legislative controls: perceptions of safety and sources of supply. Int J Drug Policy 2011, 22:120-127.
163. Wells DL, Ott CA The new marijuana. Ann Pharmacother 2011, 45:414-417.
164. Cole C, Jones L, McVeigh J, Kicman A, Syed Q, Bellis MA CUT. A guide to adulterants, bulking agents and other contaminants found in illicit drugs 2010, Centre for Public Health, Liverpool John Moores University, Liverpool, UK.
165. Baron M, Elie M, Elie L An analysis of legal highs-do they contain what it says on the tin?. Drug Test Anal 2011, 3:576-581.
166. Brandt SD, Sumnall HR, Measham F, Cole J Analyses of second-generation 'legal highs' in the UK: initial findings. Drug Test Anal 2010, 2:377-382.
167. Davies S, Lee T, Ramsey J, Dargan PI, Wood DM Risk of caffeine toxicity associated with the use of 'legal highs' (novel psychoactive substances). Eur J Clin Pharmacol 2011, 68:435-439.
168. Camilleri A, Johnston MR, Brennan M, Davis S, Caldicott DG Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathinone, 2-fluoromethamphetamine, alpha-phthalimidopropiophenone and N-ethylcathi-none. Forensic Sci Int 2010, 197:59-66.
169. Arndt T, Claussen U, Gussregen B, Schrofel S, Sturzer B, Werle A, Wolf G Kratom alkaloids and O-desmethyltramadol in urine of a Krypton herbal mixture consumer. Forensic Sci Int 2011, 208:47-52.
170. Van Hout MC, Brennan R 'Heads held high': an exploratory study of legal highs in pre-legislation Ireland. J Ethn Subst Abuse 2011, 10:256-272.
171. Vardakou I, Pistos C, Dona A, Spiliopoulou C, Athanaselis S Naphyrone: a legal high not legal any more. Drug Chem Toxicol 2012, 35:467-471.
172. ACMD Desoxypipradrol (2-DPMP) advice 2011, Advisory Council on the Misuse of Drugs, London, UK.
173. BBC News. Bristol arrest after mephedrone worth £1m found in car. Available: <>; 2011 [accessed 6/7/12]. http://www.bbc.co.uk/news/uk-england-bristol-15892016.
174. EMCDDA Trendspotter summary report. Recent shocks in the European heroin market: explanations and ramifications 2011, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal.
175. Fattore L, Fratta W Beyond THC: the new generation of cannabinoid designer drugs. Front Behav Neurosci 2011, 5:60.